Galibier Capital Management Ltd. Abb Vie Inc. Transaction History

Galibier Capital Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $1.09 Million - $1.47 Million	-13,512 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $110,055 - $147,270	-1,500 Reduced 9.99%	13,512 $1.33 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $70,369 - $106,688	-1,091 Reduced 6.78%	15,012 $1.14 Million
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $12.6 Million - $15.7 Million	-174,079 Reduced 91.53%	16,103 $1.43 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $12 Million - $14.4 Million	190,182 New	190,182 $14.4 Million

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Galibier Capital Management Ltd. with notifications on news.